Security key
00091F304
ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC)
CUSIP: 00091F304
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 409,227
- Total 13F value
- $241,042
- Share change
- +180,473
- SEC-reported price per share
- $0.59
- Number of holders
- 13
- Value change
- +$106,078
- Number of buys
- 8
- Number of sells
- 1
- Shares outstanding
- 17,410,719
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
13
Top holders
10
ABVC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
ABVC BIOPHARMA, INC. SEC filings
ABVC BIOPHARMA, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00091F304
Recent filing periods:
Ownership snapshot
Top reported holders of ABVC - ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GEODE CAPITAL MANAGEMENT,...
Disclosed value leader
GEODE CAPITAL MANAGEMENT,...
Comparable rows
9/15
Latest evidence
30 Sep 2024
13F
3/4/5
Lead comparable stake: 0.41%
6 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
GEODE CAPITAL MANAGEMENT, LLC leads the comparable SEC ownership view at 0.41%.
9 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GEODE CAPITAL MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 5
GEODE CAPITAL MANAGEMENT, LLC
0.41%
VANGUARD GROUP INC
0.27%
Avantax Planning Partners, Inc.
0.22%
XTX Topco Ltd
0.13%
NORTHERN TRUST CORP
0.11%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.41%
|
$48,935
71,607 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
0.27%
|
$32,065
46,947 shares
|
— | 30 Sep 2024 |
| Avantax Planning Partners, Inc. |
13F
Company
|
0.22%
|
$26,653
39,000 shares
|
— | 30 Sep 2024 |
| XTX Topco Ltd |
13F
Company
|
0.13%
|
$15,995
23,405 shares
|
— | 30 Sep 2024 |
| NORTHERN TRUST CORP |
13F
Company
|
0.11%
|
$13,077
19,135 shares
|
— | 30 Sep 2024 |
| STATE STREET CORP |
13F
Company
|
0.07%
|
$8,816
12,900 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
409,227
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
9
Q4 2024 holders
13
Holder diff
4
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend